Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C10H10O8 |
Molecular Weight | 258.1816 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12OC(=O)[C@@H](OC(C)=O)[C@@]1([H])OC(=O)[C@@H]2OC(C)=O
InChI
InChIKey=ZOZKYEHVNDEUCO-DKXJUACHSA-N
InChI=1S/C10H10O8/c1-3(11)15-7-5-6(18-9(7)13)8(10(14)17-5)16-4(2)12/h5-8H,1-2H3/t5-,6-,7-,8+/m0/s1
Molecular Formula | C10H10O8 |
Molecular Weight | 258.1816 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/1546564Curator's Comment: description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/6614934
Sources: http://www.ncbi.nlm.nih.gov/pubmed/1546564
Curator's Comment: description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/6614934
Aceglatone (Glucaron/ 2.5-Di-O-acetyl-D-glucaro-1,4:6,3-dilactone/ DAGDL ) is a non-toxic natural inhibitor of beta-glucuronidase. Is an antineoplastic drug available in Japan, which is used for preventive therapy after preservative operation against bladder cancer.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2728 Sources: http://www.ncbi.nlm.nih.gov/pubmed/3091283 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | Unknown Approved UseUnknown |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:46:14 GMT 2023
by
admin
on
Sat Dec 16 16:46:14 GMT 2023
|
Record UNII |
347Q3OOJ13
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1017
Created by
admin on Sat Dec 16 16:46:14 GMT 2023 , Edited by admin on Sat Dec 16 16:46:14 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2103781
Created by
admin on Sat Dec 16 16:46:14 GMT 2023 , Edited by admin on Sat Dec 16 16:46:14 GMT 2023
|
PRIMARY | |||
|
636372
Created by
admin on Sat Dec 16 16:46:14 GMT 2023 , Edited by admin on Sat Dec 16 16:46:14 GMT 2023
|
PRIMARY | |||
|
45
Created by
admin on Sat Dec 16 16:46:14 GMT 2023 , Edited by admin on Sat Dec 16 16:46:14 GMT 2023
|
PRIMARY | |||
|
C038936
Created by
admin on Sat Dec 16 16:46:14 GMT 2023 , Edited by admin on Sat Dec 16 16:46:14 GMT 2023
|
PRIMARY | |||
|
3151
Created by
admin on Sat Dec 16 16:46:14 GMT 2023 , Edited by admin on Sat Dec 16 16:46:14 GMT 2023
|
PRIMARY | |||
|
347Q3OOJ13
Created by
admin on Sat Dec 16 16:46:14 GMT 2023 , Edited by admin on Sat Dec 16 16:46:14 GMT 2023
|
PRIMARY | |||
|
SUB05207MIG
Created by
admin on Sat Dec 16 16:46:14 GMT 2023 , Edited by admin on Sat Dec 16 16:46:14 GMT 2023
|
PRIMARY | |||
|
C984
Created by
admin on Sat Dec 16 16:46:14 GMT 2023 , Edited by admin on Sat Dec 16 16:46:14 GMT 2023
|
PRIMARY | |||
|
100000087911
Created by
admin on Sat Dec 16 16:46:14 GMT 2023 , Edited by admin on Sat Dec 16 16:46:14 GMT 2023
|
PRIMARY | |||
|
ACEGLATONE
Created by
admin on Sat Dec 16 16:46:14 GMT 2023 , Edited by admin on Sat Dec 16 16:46:14 GMT 2023
|
PRIMARY | |||
|
m1
Created by
admin on Sat Dec 16 16:46:14 GMT 2023 , Edited by admin on Sat Dec 16 16:46:14 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID0048848
Created by
admin on Sat Dec 16 16:46:14 GMT 2023 , Edited by admin on Sat Dec 16 16:46:14 GMT 2023
|
PRIMARY | |||
|
642-83-1
Created by
admin on Sat Dec 16 16:46:14 GMT 2023 , Edited by admin on Sat Dec 16 16:46:14 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |